Financial Performance - The company's operating revenue for Q3 2023 reached ¥222,339,051.24, representing a year-on-year increase of 62.40%[4] - The net profit attributable to shareholders for Q3 2023 was ¥33,183,546.36, showing a significant increase of 238.16% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥16,392,153.74, with no applicable year-on-year comparison[4] - Total operating revenue for the first three quarters of 2023 reached ¥587,815,988.49, a significant increase of 127.8% compared to ¥257,824,696.48 in the same period of 2022[22] - Net profit for Q3 2023 was ¥79,122,653.17, a turnaround from a net loss of ¥22,339,753.76 in Q3 2022[23] - The total comprehensive income attributable to the parent company for Q3 2023 was CNY 79,193,163.78, a decrease of CNY 22,588,438.38 compared to the previous period[24] Assets and Liabilities - The total assets as of September 30, 2023, amounted to ¥3,336,968,736.04, reflecting a growth of 100.95% since the beginning of the year[5] - Total assets as of Q3 2023 were ¥3,336,968,736.04, compared to ¥1,660,586,174.02 in the same period last year, reflecting a growth of 100.8%[21] - The total liabilities as of September 30, 2023, are not provided, but the significant increase in current assets suggests a strengthening financial position[19] - Total liabilities decreased to ¥987,866,458.70 in Q3 2023 from ¥1,091,057,824.15 in Q3 2022, a reduction of 9.5%[21] - Total liabilities reached $1,083,453,016.56, a slight decrease from $1,091,057,824.15 in the previous quarter[30] Shareholder Equity - The equity attributable to shareholders reached ¥2,349,102,277.34, marking a substantial increase of 312.46% compared to the beginning of the year[5] - Shareholders' equity increased significantly to ¥2,349,102,277.34 in Q3 2023, compared to ¥569,528,349.87 in Q3 2022, marking a growth of 313.5%[21] - Shareholders' equity totaled $568,922,472.03, compared to $569,528,349.87 in the previous quarter[30] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥16,819,867.44, with no applicable year-on-year comparison[5] - Cash inflows from operating activities for the first three quarters of 2023 amounted to CNY 819,833,508.48, up from CNY 713,566,087.53 in the same period of 2022, representing a growth of approximately 14.87%[25] - The net cash flow from operating activities for Q3 2023 was CNY 16,819,867.44, compared to a negative cash flow of CNY 19,371,787.29 in the previous period[26] - Cash outflows from investing activities for Q3 2023 totaled CNY 1,444,628,705.22, significantly higher than CNY 256,792,425.87 in the same period of 2022[26] - The net cash flow from financing activities for Q3 2023 was CNY 1,552,609,584.14, compared to CNY 59,225,494.66 in the previous period, indicating a substantial increase[26] Research and Development - The R&D investment totaled ¥47,865,810.96 in Q3 2023, accounting for 21.53% of operating revenue, a decrease of 14.37 percentage points from the previous year[5] - Research and development expenses for Q3 2023 amounted to ¥144,561,274.39, slightly higher than ¥136,553,422.13 in Q3 2022[23] Market Strategy - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[22] - The company has indicated a focus on strategic acquisitions to enhance its competitive position in the market[22] Other Financial Metrics - The basic earnings per share for Q3 2023 was ¥0.10, an increase of 153.62% year-on-year[5] - The weighted average return on equity for the year-to-date period was 5.79%, indicating an improvement in profitability compared to the previous year[5] - The company reported a financial income of ¥8,441,009.50 in Q3 2023, up from ¥2,522,765.74 in Q3 2022[23] - The company reported a total tax payment of CNY 32,748,555.11 for Q3 2023, compared to CNY 1,733,124.81 in the previous period[26]

证券代码：688361 证券简称：中科飞测 公告编号：2023-019 深圳中科飞测科技股份有限公司 关于 2023 年前三季度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 计提减值准备的情况概述 深圳中科飞测科技股份有限公司（以下简称"公司"）根据《企业会计准则 第 8 号——资产减值》《企业会计准则第 22 号——金融工具确认和计量》（以下 合称"《企业会计准则》"）和相关会计政策的规定，结合公司的实际情况，为 客观、公允地反映公司截至 2023 年 9 月 30 日的财务状况和 2023 年 1-9 月的经 营成果，公司对截至 2023 年 9 月 30 日合并范围内存在减值迹象的资产进行了减 值测试并计提了相应的减值准备，预计 2023 年 1-9 月公司计提信用减值损失及 资产减值损失共计人民币 12,379,677.01 元，具体情况如下： 单位：人民币元 | 项目 | 2023 | 年 1-9 | 月计提金额 | 备注 | | --- | --- | --- | --- | - ...

国泰君安证券股份有限公司 关于深圳中科飞测科技股份有限公司使用自有资金、银行 信贷资金等支付募投项目部分款项并以募集资金等额置换 的核查意见 国泰君安证券股份有限公司（以下简称"国泰君安"、"保荐人"）作为深圳 中科飞测科技股份有限公司（以下简称"中科飞测"或"公司"）首次公开发行 股票并在科创板上市的持续督导机构，根据《上市公司监管指引第 2 号——上市 公司募集资金管理和使用的监管要求》（以下简称"《上市公司监管指引第 2 号》"） 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》（以下简 称"《自律监管指引第 1 号》"）等有关规定，对中科飞测使用自有资金、银行信 贷资金等支付募投项目部分款项并以募集资金等额置换的事项进行了审慎核查， 具体情况如下： 三、使用自有资金、银行信贷资金等支付募投项目部分款项并以募集 资金等额置换的原因及操作流程 （一）使用自有资金、银行信贷资金等支付募投项目部分款项并以募集资金 等额置换的原因 公司在募投项目实施过程中，根据募集资金专款专用原则，全部支出均应从 募集资金专户直接支付划转。但在募投项目实施期间，公司存在使用自有资金、 银行信贷资金支付募投项目 ...

证券代码：688361 证券简称：中科飞测 公告编号：2023-020 深圳中科飞测科技股份有限公司 关于获得政府补助的公告 二、 补助的类型及对上市公司的影响 公司根据《企业会计准则第 16 号——政府补助》等相关规定，确认上述事 项并划分补助类型，预计对公司 2023 年度的利润产生一定的积极影响。上述政 府补助未经审计，具体的会计处理以及对公司相关年度损益的影响须以审计机构 年度审计确认后的结果为准。敬请投资者注意投资风险。 特此公告。 深圳中科飞测科技股份有限公司 董事会 2023 年 10 月 27 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 获取补助的基本情况 深圳中科飞测科技股份有限公司（以下简称"公司"）于 2023 年 10 月 25 日收到人民币 300.00 万元的政府补助款，均为与收益相关的政府补助。 ...

深圳中科飞测科技股份有限公司独立董事 关于公司第一届董事会第二十七次会议相关议案的独立意见 深圳中科飞测科技股份有限公司（以下简称"公司"）第一届董事会第二十七 次会议于 2023 年 10 月 26 日以通讯方式召开，作为公司独立董事，在认真阅读 相关会议资料并对有关情况进行详细了解后，我们根据《中华人民共和国公司法》 《中华人民共和国证券法》等法律法规及《深圳中科飞测科技股份有限公司章程》 《深圳中科飞测科技股份有限公司独立董事工作细则》的要求，基于客观、独立 判断立场，对相关议案发表如下独立意见： 一、 对《关于使用自有资金、银行信贷资金等支付募投项目部分款项并 以募集资金等额置换的议案》的独立意见 公司于 2023 年 10 月 26 日分别召开了第一届董事会第二十七次会议和第一 届监事会第二十三次会议，审议通过了《关于使用自有资金、银行信贷资金等支 付募投项目部分款项并以募集资金等额置换的议案》，同意公司在募集资金投资 项目（以下简称"募投项目"）实施期间，使用自有资金、银行信贷资金等支付 募投项目部分款项并以募集资金等额置换，并明确了上述等额置换的具体操作流 程规范。 对上述事项我们进行了现场检查 ...

证券代码：688361 证券简称：中科飞测 公告编号：2023-018 深圳中科飞测科技股份有限公司 关于使用自有资金、银行信贷资金等支付募投项目部分款 项并以募集资金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳中科飞测科技股份有限公司（以下简称"公司"）于 2023 年 10 月 26 日 分别召开了第一届董事会第二十七次会议和第一届监事会第二十三次会议，审议 通过了《关于使用自有资金、银行信贷资金等支付募投项目部分款项并以募集资 金等额置换的议案》，同意公司在募集资金投资项目（以下简称"募投项目"） 实施期间，使用自有资金、银行信贷资金等支付募投项目部分款项并以募集资金 等额置换，并明确了上述等额置换的具体操作流程规范。公司监事会、独立董事 对以上事项发表了明确同意的意见，保荐机构国泰君安证券股份有限公司（以下 简称"保荐机构"）对此出具明确的核查意见。现将具体情况公告如下： 一、 募集资金基本情况 经中国证券监督管理委员会《关于同意深圳中科飞测科技股份有限公司首次 公开发行股票注册的批复》（证 ...

证券代码：688361 证券简称：中科飞测 公告编号：2023-017 深圳中科飞测科技股份有限公司 第一届监事会第二十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 深圳中科飞测科技股份有限公司（以下简称"公司"）第一届监事会第二十 三次会议于 2023 年 10 月 26 日以通讯表决方式在公司会议室召开，会议通知于 2023 年 10 月 20 日以电子邮件方式送达至全体监事。本次会议应到监事 3 人， 实到监事 3 人，会议由监事会主席陈彬女士召集并主持。会议的召集和召开程序 符合《中华人民共和国公司法》和《深圳中科飞测科技股份有限公司章程》等相 关规定，会议形成的决议合法、有效。 二、 监事会会议审议情况 经与会监事充分讨论，会议形成一致决议如下： （一）审议通过《关于公司 2023 年第三季度报告的议案》 监事会认为：公司 2023 年第三季度报告的编制和审议程序符合《上海证券 交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作 ...

国泰君安证券股份有限公司 关于深圳中科飞测科技股份有限公司 2023 年半年度持续督导跟踪报告 国泰君安证券股份有限公司（以下简称"国泰君安"）作为深圳中科飞测科 技股份有限公司（以下简称"中科飞测"或"公司"）首次公开发行股票并在科 创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交易所 科创板股票上市规则》《上海证券交易所上市公司持续督导工作指引》等相关规 定，作为公司持续督导工作的保荐人，负责中科飞测上市后的持续督导工作，并 出具本持续督导跟踪报告。 一、持续督导工作情况 | 工作内容 | 持续督导情况 | | --- | --- | | （一）持续督导事项 | 证券上市当年剩余时间及其后 3 个完整会计年度 | | 1、督导发行人有效执行并完善防 | | | 止主要股东、其他关联方违规占用 | 年上半年，中科飞测不存在前述情形 2023 | | 发行人资源的制度 | | | | 年上半年，保荐人督导中科飞测有效执行并进 2023 | | 2、督导发行人有效执行并完善防 | 一步完善防止高级管理人员利用职务之便损害发行 | | 止其高级管理人员利用职务之便 | 人利益的内控制度；与发行人 ...

深圳中科飞测科技股份有限公司（以下简称"公司"）已于 2023 年 8 月 25 日发布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半年度经营成果、财务状况，公司计划于 2023 年 9 月 15 日（星期五）上午 10:00-11:30 举行 2023 年半年度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 深圳中科飞测科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 投资者可于 2023 年 9 月 8 日（星期五）至 9 月 14 日（星期四）16:00 前登录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公 司 邮 箱 IR@skyverse.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 证券代码：688361 证券简称：中科飞测 公告编号：2023-016 本次业绩说明会以视频录播结合网络互动召开，公司将针对 2023 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of 500 million RMB, representing a 25% year-over-year growth[1]. - The company's operating revenue for the first half of 2023 reached RMB 365,476,937.25, representing a 202.25% increase compared to RMB 120,918,962.99 in the same period last year[17]. - The net profit attributable to shareholders of the listed company was RMB 45,939,106.81, a significant recovery from a loss of RMB 32,152,733.47 in the previous year[17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 2,353,416.48, improving from a loss of RMB 74,106,775.16 in the same period last year[17]. - The net cash flow from operating activities was RMB 51,874,855.18, a decrease of 8.33% compared to RMB 56,590,143.02 in the previous year[17]. - The company achieved significant progress in measurement equipment for 2Xnm process nodes, receiving multiple orders from leading domestic clients after successful validation on production lines[54]. - The company reported a net profit of ¥10,120,712.63 for the first half of 2023, compared to a net loss in the same period of 2022, indicating a turnaround in profitability[187]. - The company reported a total comprehensive income for the first half of 2023 of ¥56,474,725.01, contrasting with a total comprehensive loss of -¥27,039,671.61 in the first half of 2022[191]. Research and Development - The company is investing heavily in R&D, with a budget increase of 20% to enhance technology development and innovation[1]. - R&D investment accounted for 26.46% of operating revenue, a decrease of 45.82 percentage points compared to the previous year, while R&D expenditure increased by 10.64% to 96.70 million yuan[20]. - The company is actively engaged in the research and development of new products and technologies to maintain competitive advantages[12]. - The company has developed nine core technologies, including deep ultraviolet imaging scanning technology and high-precision multi-mode interference measurement technology, enhancing its competitive edge[49]. - The company holds a total of 856 patent applications, with 401 granted, including 41 new invention patent applications and 18 granted in the current period[41]. - The company plans to explore potential mergers and acquisitions to accelerate growth and market expansion[12]. Market Expansion and Strategy - User data indicates a growing customer base, with active users increasing by 15% to reach 1.2 million by the end of June 2023[1]. - Market expansion plans include entering three new international markets by the end of 2023, aiming for a 10% market share in each[1]. - A new marketing strategy has been implemented, focusing on digital channels, which is expected to increase customer engagement by 40%[1]. - The company is considering strategic acquisitions to bolster its market position, with potential targets identified in the semiconductor sector[1]. - The company is focused on expanding its market presence and enhancing its technological capabilities in the semiconductor industry[12]. Financial Position and Assets - The company has maintained a strong balance sheet, with total assets reported at 1.5 billion RMB and a debt-to-equity ratio of 0.3[1]. - Total assets reached RMB 3,445,147,390.02, reflecting a 107.47% increase compared to RMB 1,660,586,174.02 at the end of the previous year[17]. - The net assets attributable to shareholders of the listed company increased to RMB 2,315,104,684.82, a 306.50% increase from RMB 569,528,349.87 at the end of the previous year[17]. - The company reported a significant increase in cash and cash equivalents, totaling ¥1,857,972,986.50, which represents 53.93% of total assets, up 673.23% from ¥240,286,868.21 last year[67]. - The company’s total capital at the beginning of the year was 240,000,000 RMB, which remained unchanged throughout the reporting period[199]. Risks and Challenges - No significant risks have been identified that could impact the company's operations in the near term, ensuring stability for ongoing projects[1]. - The company faces risks related to high customer concentration, with the top five customers accounting for a significant portion of revenue, necessitating ongoing market expansion efforts[56]. - The company faces risks related to supply chain disruptions, particularly for core components sourced from overseas suppliers, which could impact production schedules[60]. - The company reported accounts receivable of 139.38 million yuan, highlighting potential risks in timely collection amid economic fluctuations[58]. - The company's inventory value stood at 996.56 million yuan, with risks associated with potential inventory write-downs if market conditions change[58]. Shareholder Commitments and Governance - The company has committed to a 36-month lock-up period for major shareholders following the IPO, ensuring stability in shareholding[87]. - The company has successfully maintained compliance with all commitments made during the IPO process, ensuring timely execution[88]. - The company has a structured approach to managing shareholder intentions and commitments, which is crucial for long-term stability[90]. - The company will ensure compliance with legal obligations regarding compensation for any losses incurred due to non-fulfillment of commitments[98]. - The company has a policy to limit any share reduction to no more than 2% of total shares in the fourth and fifth fiscal years post-IPO if not profitable[99]. Future Outlook - The company has provided a positive outlook for the second half of 2023, projecting a revenue growth of 30% compared to the same period last year[1]. - Future outlook indicates a commitment to improving operational efficiency and increasing production capacity to meet growing market demands[12]. - The company plans to enhance its production capacity through fundraising projects focused on high-end semiconductor quality control equipment and R&D center upgrades[61]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[187].